ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 458

The Influence of Mediterranean Diet in Rheumatoid Arthritis: A Monocenter Cross-sectional Study

Francesca Ingegnoli1, Tommaso Schioppo 1, Isabella Scotti 2, Giuseppe Marano 2, Patrizia Boracchi 2, Orazio De Lucia 3, Antonella Murgo 3 and Roberto Caporali 1, 1Division of Clinical Rheumatology, ASST Pini-CTO, Università degli Studi di Milano, Department of Clinical Sciences and Community Health, Milan, Italy, Milano, Italy, 2Università degli Studi di Milano, Milano, Italy, MILANO, Italy, 3Division of Clinical Rheumatology, ASST Pini-CTO, Milan, Italy, Milano, Italy

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: diet and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Mediterranean diet (MD) is considered a well-balanced and potentially anti-inflammatory diet characterized by high consumption of olive oil, unrefined cereals, fresh or dried fruit and vegetables, fish, dairy products, meat and with a moderate amount of red wine. Currently, there is conflicting data for the benefits of MD in rheumatoid arthritis (RA), and not enough evidence to support a role of MD in the prevention and treatment of RA.

The aim of our study was to evaluate the association between MD adherence and disease activity, general health (GH) and comorbidities in patients with RA.

Methods: Consecutive patients with RA (ACR/EULAR Criteria 2010) were enrolled in this cross-sectional study. For each patient, Disease Activity Score on 28 joints (DAS28), Simple Disease Activity Index (SDAI), patient GH and a self-reported questionnaire called MD score were recorded. The association between MD score and the above mentioned variables was assessed through univariate regression models (MD score as response variable and the variables of interest as independent variables). Results from each model were reported in terms of: 1) test of association (Likelihood Ratio test, with a Chi-square distribution); 2) categorical independent variables, estimated differences of mean MD score between groups, with respective 95% CI; 3) numerical independent variables, estimate of correlation coefficient and regression slope coefficient, with respective 95% CI. The analysis was performed using the R software.

Results: 205 RA patients (197 Italian) were enrolled: median age at visit 53 (q1-q3: 44-59) years, age at onset 38 (q1-q3: 28-47), disease duration 12 (q1-q3: 7-19), female 80.49%, rheumatoid factor and/or anti–citrullinated protein antibody positivity 58.54%, radiographic damage 41.79%. Comorbidities were also assessed: gastrointestinal 19% (gastro-esophageal reflux disease; inflammatory bowel disease; gastritis; esophagitis), chronic renal failure 1%, arterial hypertension 21.95%, diabetes mellitus 3.9% and coronary artery disease 1.95%. A significant positive correlation was found between MD score and GH, as shown in the table. This suggests a low/moderate tendency of having better GH with higher MD score. Although not statistically significant, a negative correlation was found with DAS28 and SDAI, suggesting an association between higher MD score with lower disease activity. Among comorbidities, a significant difference of mean MD score values between subjects with and without arterial hypertension was also found (mean difference -2.0 CI: -3.7, -0.2; p=0.029).

Conclusion: In this Italian RA cohort, the adherence to MD was significantly associated with a better GH, but higher MD score was not significantly associated with lower disease activity. Arterial hypertension was the only comorbidity associated with lower MD score, probably due to the fact that the prevalence of the other comorbidities was low. Our study suggests an overall beneficial effect of MD in RA patients. Further studies are needed to better understand the impact of lifestyle modification (e.g. diet) in achieving RA disease control.


Disclosure: F. Ingegnoli, None; T. Schioppo, None; I. Scotti, None; G. Marano, None; P. Boracchi, None; O. De Lucia, None; A. Murgo, None; R. Caporali, None.

To cite this abstract in AMA style:

Ingegnoli F, Schioppo T, Scotti I, Marano G, Boracchi P, De Lucia O, Murgo A, Caporali R. The Influence of Mediterranean Diet in Rheumatoid Arthritis: A Monocenter Cross-sectional Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-influence-of-mediterranean-diet-in-rheumatoid-arthritis-a-monocenter-cross-sectional-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-influence-of-mediterranean-diet-in-rheumatoid-arthritis-a-monocenter-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology